AI-Driven Tools Boost U.S. Medical Device Development
MWN-AI** Summary
U.S. medical device companies are increasingly implementing AI-driven tools and digital-first strategies to enhance product development and post-market monitoring, as highlighted in the 2025 ISG Provider Lens® Medical Device Digital Services report by Information Services Group (ISG). This shift is largely in response to rising compliance demands and cybersecurity challenges, pressing manufacturers to adopt patient-centric operational models for expedited innovation.
The report observes a significant modernization in the approach to product engineering, where companies leverage connected technologies, data analytics, and sustainability initiatives to improve efficiency and patient outcomes amidst a stringent regulatory landscape. AI plays a crucial role; it enables quicker time-to-market for devices through advanced simulation methods and real-time performance data analysis, while digital twins facilitate personalized patient care by modeling both devices and human systems.
Moreover, U.S. manufacturers are bolstering their regulatory compliance by integrating digital quality management systems that automate documentation and risk assessments, thus minimizing administrative burdens and enhancing audit readiness. By embedding compliance into device design, manufacturers ensure stronger traceability and reduce the likelihood of costly post-market revisions.
A focus on enhancing user experience has led to investments in intuitive device interfaces and usability features, which aim to improve patients' adherence to treatment protocols. Advances in post-market surveillance allow manufacturers to continuously monitor device safety and gather real-world evidence for ongoing improvements.
Prominent players like Accenture, Deloitte, and others are recognized as leaders in various categories, underscoring the partnership opportunities needed to sustain innovation in the medical device field. As digital engineering evolves, the emphasis on compliance, technology integration, and human-centered design is setting new standards for medical device innovation.
MWN-AI** Analysis
The U.S. medical device industry is experiencing a transformative wave driven by AI-powered tools, which significantly enhance product development, regulatory compliance, and post-market monitoring. Companies are increasingly adopting digital-first, patient-centered models to accelerate innovation while addressing compliance and cybersecurity challenges. According to the 2025 ISG Provider Lens report, these strategies are essential as enterprises navigate rising regulatory scrutiny and cost pressures.
Investing in advanced digital engineering technologies like AI, digital twins, and simulation is crucial for manufacturers looking to reduce time-to-market and improve product quality. These tools allow for real-time performance analysis and predictive diagnostics, enabling a more dynamic design-validation process. Notably, the integration of digital quality management systems allows organizations to streamline compliance activities, further improving operational efficiency. This data-driven approach not only supports adherence to new regulatory frameworks, such as the FDA's Quality Management System Regulation, but also enhances traceability, reducing the risk of costly post-market revisions.
In this landscape, patient-centric design is paramount. Manufacturers focused on intuitive interfaces and enhanced accessibility are more likely to drive patient engagement and adherence to treatment plans. As real-world evidence becomes increasingly important for product improvements, companies leveraging advanced post-market surveillance and analytics will be better positioned to meet evolving patient and regulatory demands.
For investors, companies recognized as leaders in the ISG analysis—including Accenture, Capgemini, and Cognizant—are worth watching as they innovate at the intersection of technology and healthcare. Additionally, organizations that align with service providers specializing in digital transformation within the medical device sector are more likely to thrive. Overall, the convergence of AI and healthcare offers profound investment opportunities, particularly for those prioritizing safety, efficiency, and enhanced patient outcomes.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Manufacturers modernize product engineering, post-market monitoring for faster product rollouts, ongoing improvements, ISG Provider Lens ® report says
U.S. medical device companies are adopting digital-first and patient-centric operating models to accelerate innovation while meeting rising compliance and cybersecurity requirements, according to a new research report published today by Information Services Group ( ISG ) (Nasdaq: III ), a global AI-centered technology research and advisory firm.
The 2025 ISG Provider Lens ® Medical Device Digital Services report for the U.S. finds enterprises are modernizing their product development and post-market digital enablement processes with connected technologies, data-driven quality assurance and sustainability initiatives. As manufacturers face increasing regulatory scrutiny and cost pressures, they are using advanced digital tools to enhance safety, efficiency and patient outcomes while complying with evolving standards.
“U.S. medical device makers are transforming how they design, validate and monitor products,” said Jenn Stein, ISG partner and life sciences industry lead. “By embedding digital compliance and patient-centric design into their operations, they are enhancing agility and trust.”
Digital engineering is helping enterprises reduce time to market and introduce new features without compromising quality. U.S. manufacturers are integrating AI, digital twins and advanced simulation into design and testing to speed product development, the report says. These tools perform real-time analysis of performance data, predictive diagnostics and virtual validation of prototypes. Digital twins are increasingly used to model not just devices but human systems, which helps to make more personalized care possible.
U.S. companies are adopting digital quality management systems and regulatory intelligence platforms to strengthen compliance and reduce administrative burdens, ISG says. AI is helping to make this possible by streamlining documentation, automating risk-based validation and supporting continuous audit readiness. These systems are becoming essential as firms adapt to new frameworks such as the U.S. Food and Drug Administration’s Quality Management System Regulation (QMSR). By embedding compliance in the design of devices, organizations improve traceability and prevent costly post-market revisions.
A growing focus on patients’ needs is reshaping product strategy, the report says. Manufacturers are investing in intuitive interfaces and accessibility features to enhance device usability, which can improve patients’ adherence to care plans. Advances in post-market surveillance and analytics help companies monitor safety, obtain real-world evidence and formulate product improvements. This data-driven approach lets companies respond proactively to patient and regulatory requirements.
“Enterprises that combine compliance, technology and human-centered design are setting new standards for medical innovation,” said Rohan Sinha, senior manager and principal analyst, ISG Provider Lens Research, and lead author of the report. “Service partners play a key role in enabling these companies to safely and ethically invent the future of medical devices.”
The report also explores other medical device trends in the U.S., including the use of eco-friendly materials for sustainability and secure cloud architectures for data protection.
For more insights into the technology-related challenges faced by medical device enterprises in the U.S., plus ISG’s advice for overcoming them, see the ISG Provider Lens ® Focal Points briefing here .
The 2025 ISG Provider Lens ® Medical Devices report for the U.S. evaluates the capabilities of 20 providers across three quadrants: Digital Engineering and Product Development; Regulatory Compliance, Strategy and Quality Assurance; and Post-market Digital Enablement.
The report names Accenture, Capgemini, Cognizant, HCLTech, Infosys, LTTS, TCS and Wipro as Leaders in three quadrants each. It names Deloitte as a Leader in two quadrants.
In addition, HARMAN, Hexaware and LTIMindtree are recognized as Rising Stars — companies with a “promising portfolio” and “high future potential” by ISG’s definition — in one quadrant each.
Customized versions of the report are available from Hexaware and LTTS .
The 2025 ISG Provider Lens ® Medical Device Digital Services report for the U.S. is available to subscribers or for one-time purchase on this webpage .
About ISG Provider Lens ® Research
The ISG Provider Lens ® Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Canada, Mexico, Brazil, the U.K., France, Benelux, Germany, Switzerland, the Nordics, Australia and Singapore/Malaysia, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage .
About ISG
ISG (Nasdaq: III ) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world’s top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251023023929/en/
Press Contacts:
Laura Hupprich, ISG
+1 203-517-3100
laura.hupprich@isg-one.com
Julianna Sheridan, Matter Communications for ISG
+1 978-518-4520
isg@matternow.com
FAQ**
How is Information Services Group Inc. III leveraging AI to facilitate compliance in U.S. medical device companies, and what specific tools or technologies are being adopted for this purpose?
What role does Information Services Group Inc. III see for digital twins in enhancing product design and patient care within the medical device sector?
In what ways are U.S. manufacturers responding to rising compliance and cybersecurity requirements according to the Information Services Group Inc. III report?
How could the trends identified by Information Services Group Inc. III impact the future landscape of medical device manufacturing and regulatory practices?
**MWN-AI FAQ is based on asking OpenAI questions about Information Services Group Inc. (NASDAQ: III).
NASDAQ: III
III Trading
-1.52% G/L:
$4.225 Last:
34,238 Volume:
$4.17 Open:
